TY  - GEN 
AU  - Muñoz-Rivas, N.
AU  - Aibar, J.
AU  - Gabara-Xancó, C.
AU  - Trueba-Vicente, Á.
AU  - Urbelz-Pérez, A.
AU  - Gómez-Del Olmo, V.
AU  - Demelo-Rodríguez, P.
AU  - Rivera Gallego, Alberto
AU  - Bosch-Nicolau, P.
AU  - Perez-Pinar, M.
AU  - Rios-Prego, M.
AU  - Madridano-Cobo, O.
AU  - Ramos-Alonso, L.
AU  - Alonso-Carrillo, J.
AU  - Francisco-Albelsa, I.
AU  - Martí-Saez, E.
AU  - Maestre-Peiró, A.
AU  - Méndez-Bailón, M.
AU  - Hernández-Rivas, J.Á.
AU  - Torres-Macho, J.
PY  - 2022
SN  - 2077-0383
UR  - http://hdl.handle.net/20.500.11940/20887
AB  - Hospitalized patients with COVID-19 are at increased risk of thrombosis, acute respiratory distress syndrome and death. The optimal dosage of thromboprophylaxis is unknown. The aim was to evaluate the efficacy and safety of tinzaparin in prophylactic,...
LA  - eng
TI  - Efficacy and Safety of Tinzaparin in Prophylactic, Intermediate and Therapeutic Doses in Non-Critically Ill Patients Hospitalized with COVID-19: The PROTHROMCOVID Randomized Controlled Trial
DO  - 10.3390/jcm11195632
KW  - AS Vigo
KW  - CHUVI
KW  - IISGS
VL  - 11
ER  -